References
Belhadj, S., Quintana, I., Mur, P., Munoz-Torres, P. M., Alonso, M. H., Navarro, M., … Valle, L. (2019). NTHL1 biallelic mutations seldom cause colorectal cancer, serrated polyposis or a multi-tumor phenotype, in absence of colorectal adenomas. Scientific Reports ,9 (1), 9020. https://doi.org/10.1038/s41598-019-45281-1
Bellavia, S., Dahan, K., Terryn, S., Cosyns, J.-P., Devuyst, O., & Pirson, Y. (2010). A homozygous mutation in INVS causing juvenile nephronophthisis with abnormal reactivity of the Wnt/beta-catenin pathway. Nephrology, Dialysis, Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association , 25 (12), 4097–4102. https://doi.org/10.1093/ndt/gfq519
Besco, J. A., Hooft van Huijsduijnen, R., Frostholm, A., & Rotter, A. (2006). Intracellular substrates of brain-enriched receptor protein tyrosine phosphatase rho (RPTPrho/PTPRT). Brain Research ,1116 (1), 50–57. https://doi.org/10.1016/j.brainres.2006.07.122
Bromberg, J. F., Wrzeszczynska, M. H., Devgan, G., Zhao, Y., Pestell, R. G., Albanese, C., & Darnell, J. E. (1999). Stat3 as an oncogene.Cell , 98 (3), 295–303.
Chu, Q., Shen, D., He, L., Wang, H., Liu, C., & Zhang, W. (2017). Prognostic significance of SOCS3 and its biological function in colorectal cancer. Gene , 627 , 114–122. https://doi.org/10.1016/j.gene.2017.06.013
Darnell, J. E. (2005). Validating Stat3 in cancer therapy. Nature Medicine , 11 (6), 595–596. https://doi.org/10.1038/nm0605-595
Esteban-Jurado, C., Franch-Expósito, S., Muñoz, J., Ocaña, T., Carballal, S., López-Cerón, M., … Castellví-Bel, S. (2016). The Fanconi anemia DNA damage repair pathway in the spotlight for germline predisposition to colorectal cancer. European Journal of Human Genetics: EJHG , 24 (10), 1501–1505. https://doi.org/10.1038/ejhg.2016.44
Evans, D. R., Green, J. S., & Woods, M. O. (2018). Screening of BMPR1a for pathogenic mutations in familial colorectal cancer type X families from Newfoundland. Familial Cancer , 17 (2), 205–208. https://doi.org/10.1007/s10689-017-0016-8
Garre, P., Briceno, V., Xicola, R. M., Doyle, B. J., de la Hoya, M., Sanz, J., … Caldes, T. (2011). Analysis of the Oxidative Damage Repair Genes NUDT1, OGG1, and MUTYH in Patients from Mismatch Repair Proficient HNPCC Families (MSS-HNPCC). Clinical Cancer Research ,17 (7), 1701–1712. https://doi.org/10.1158/1078-0432.CCR-10-2491
Garre, P., Martín, L., Sanz, J., Romero, A., Tosar, A., Bando, I., … Caldés, T. (2015). BRCA2 gene: A candidate for clinical testing in familial colorectal cancer type X. Clinical Genetics ,87 (6), 582–587. https://doi.org/10.1111/cge.12427
Gaston, D., Hansford, S., Oliveira, C., Nightingale, M., Pinheiro, H., Macgillivray, C., … Bedard, K. (2014). Germline mutations in MAP3K6 are associated with familial gastric cancer. PLoS Genetics , 10 (10), e1004669. https://doi.org/10.1371/journal.pgen.1004669
Hunter, T. (2009). Tyrosine phosphorylation: Thirty years and counting.Current Opinion in Cell Biology , 21 (2), 140–146. https://doi.org/10.1016/j.ceb.2009.01.028
Inagaki-Ohara, K., Kondo, T., Ito, M., & Yoshimura, A. (2013). SOCS, inflammation, and cancer. JAK-STAT , 2 (3), e24053. https://doi.org/10.4161/jkst.24053
Jiang, M., Zhang, W., Liu, P., Yu, W., Liu, T., & Yu, J. (2017). Dysregulation of SOCS-Mediated Negative Feedback of Cytokine Signaling in Carcinogenesis and Its Significance in Cancer Treatment.Frontiers in Immunology , 8 . https://doi.org/10.3389/fimmu.2017.00070
Julien, S. G., Dubé, N., Hardy, S., & Tremblay, M. L. (2011). Inside the human cancer tyrosine phosphatome. Nature Reviews. Cancer ,11 (1), 35–49. https://doi.org/10.1038/nrc2980
Laczmanska, I., Karpinski, P., Bebenek, M., Sedziak, T., Ramsey, D., Szmida, E., & Sasiadek, M. M. (2013). Protein tyrosine phosphatase receptor-like genes are frequently hypermethylated in sporadic colorectal cancer. Journal of Human Genetics , 58 (1), 11–15. https://doi.org/10.1038/jhg.2012.119
Lindor, N. M. (2009). Familial colorectal cancer type X: The other half of hereditary nonpolyposis colon cancer syndrome. Surgical Oncology Clinics of North America , 18 (4), 637–645. https://doi.org/10.1016/j.soc.2009.07.003
Lui, V. W. Y., Peyser, N. D., Ng, P. K.-S., Hritz, J., Zeng, Y., Lu, Y., … Grandis, J. R. (2014). Frequent mutation of receptor protein tyrosine phosphatases provides a mechanism for STAT3 hyperactivation in head and neck cancer. Proceedings of the National Academy of Sciences of the United States of America , 111 (3), 1114–1119. https://doi.org/10.1073/pnas.1319551111
Martín-Morales, L., Feldman, M., Vershinin, Z., Garre, P., Caldés, T., & Levy, D. (2017). SETD6 dominant negative mutation in familial colorectal cancer type X. Human Molecular Genetics ,26 (22), 4481–4493. https://doi.org/10.1093/hmg/ddx336
Nieminen, T. T., O’Donohue, M.-F., Wu, Y., Lohi, H., Scherer, S. W., Paterson, A. D., … Peltomäki, P. (2014). Germline Mutation of RPS20, Encoding a Ribosomal Protein, Causes Predisposition to Hereditary Nonpolyposis Colorectal Carcinoma Without DNA Mismatch Repair Deficiency. Gastroenterology , 147 (3), 595-598.e5. https://doi.org/10.1053/j.gastro.2014.06.009
Peyser, N. D., Freilino, M., Wang, L., Zeng, Y., Li, H., Johnson, D. E., & Grandis, J. R. (2016). Frequent promoter hypermethylation of PTPRT increases STAT3 activation and sensitivity to STAT3 inhibition in head and neck cancer. Oncogene , 35 (9), 1163–1169. https://doi.org/10.1038/onc.2015.171
Puente, X. S., Pinyol, M., Quesada, V., Conde, L., Ordóñez, G. R., Villamor, N., … Campo, E. (2011). Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia.Nature , 475 (7354), 101–105. https://doi.org/10.1038/nature10113
Scherr, A.-L., Gdynia, G., Salou, M., Radhakrishnan, P., Duglova, K., Heller, A., … Koehler, B. C. (2016). Bcl-xL is an oncogenic driver in colorectal cancer. Cell Death & Disease , 7 (8), e2342–e2342. https://doi.org/10.1038/cddis.2016.233
Schulz, E., Klampfl, P., Holzapfel, S., Janecke, A. R., Ulz, P., Renner, W., … Sill, H. (2014). Germline variants in the SEMA4A gene predispose to familial colorectal cancer type X. Nature Communications , 5 , 5191. https://doi.org/10.1038/ncomms6191
Seguí, N., Mina, L. B., Lázaro, C., Sanz-Pamplona, R., Pons, T., Navarro, M., … Valle, L. (2015). Germline Mutations in FAN1 Cause Hereditary Colorectal Cancer by Impairing DNA Repair.Gastroenterology , 149 (3), 563–566. https://doi.org/10.1053/j.gastro.2015.05.056
Simons, M., Gloy, J., Ganner, A., Bullerkotte, A., Bashkurov, M., Krönig, C., … Walz, G. (2005). Inversin, the gene product mutated in nephronophthisis type II, functions as a molecular switch between Wnt signaling pathways. Nature Genetics , 37 (5), 537–543. https://doi.org/10.1038/ng1552
Singh, V., Ram, M., Kumar, R., Prasad, R., Roy, B. K., & Singh, K. K. (2017). Phosphorylation: Implications in Cancer. The Protein Journal , 36 (1), 1–6. https://doi.org/10.1007/s10930-017-9696-z
Smith, C. G., Naven, M., Harris, R., Colley, J., West, H., Li, N., … Cheadle, J. P. (2013). Exome Resequencing Identifies Potential Tumor-Suppressor Genes that Predispose to Colorectal Cancer. Human Mutation , 34 (7), 1026–1034. https://doi.org/10.1002/humu.22333
Tate, J. G., Bamford, S., Jubb, H. C., Sondka, Z., Beare, D. M., Bindal, N., … Forbes, S. A. (2019). COSMIC: The Catalogue Of Somatic Mutations In Cancer. Nucleic Acids Research , 47 (D1), D941–D947. https://doi.org/10.1093/nar/gky1015
Terradas, M., Munoz-Torres, P. M., Belhadj, S., Aiza, G., Navarro, M., Brunet, J., … Valle, L. (2019). Contribution to colonic polyposis of recently proposed predisposing genes and assessment of the prevalence of NTHL1- and MSH3-associated polyposes. Human Mutation . https://doi.org/10.1002/humu.23853
Tonks, N. K. (2006). Protein tyrosine phosphatases: From genes, to function, to disease. Nature Reviews. Molecular Cell Biology ,7 (11), 833–846. https://doi.org/10.1038/nrm2039
Umar, A., Boland, C. R., Terdiman, J. P., Syngal, S., de la Chapelle, A., Rüschoff, J., … Srivastava, S. (2004). Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. Journal of the National Cancer Institute , 96 (4), 261–268.
Unoki, M., & Nakamura, Y. (2001). Growth-suppressive effects of BPOZ and EGR2, two genes involved in the PTEN signaling pathway.Oncogene , 20 (33), 4457–4465. https://doi.org/10.1038/sj.onc.1204608
Valle, L. (2017). Recent Discoveries in the Genetics of Familial Colorectal Cancer and Polyposis. Clinical Gastroenterology and Hepatology , 15 (6), 809–819. https://doi.org/10.1016/j.cgh.2016.09.148
Vasen, H. F., Mecklin, J. P., Khan, P. M., & Lynch, H. T. (1991). The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC). Diseases of the Colon and Rectum ,34 (5), 424–425.
Vasen, H. F., Watson, P., Mecklin, J. P., & Lynch, H. T. (1999). New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology , 116 (6), 1453–1456.
Wang, L.-E., Gorlova, O. Y., Ying, J., Qiao, Y., Weng, S.-F., Lee, A. T., … Wei, Q. (2013). Genome-wide association study reveals novel genetic determinants of DNA repair capacity in lung cancer. Cancer Research , 73 (1), 256–264. https://doi.org/10.1158/0008-5472.CAN-12-1915
Wang, Z., Shen, D., Parsons, D. W., Bardelli, A., Sager, J., Szabo, S., … Velculescu, V. E. (2004). Mutational analysis of the tyrosine phosphatome in colorectal cancers. Science (New York, N.Y.) ,304 (5674), 1164–1166. https://doi.org/10.1126/science.1096096
Zetner, D. B., & Bisgaard, M. L. (2017). Familial Colorectal Cancer Type X. Current Genomics , 18 (4). https://doi.org/10.2174/1389202918666170307161643
Zhang, P., Zhao, Y., Zhu, X., Sedwick, D., Zhang, X., & Wang, Z. (2011). Cross-talk between phospho-STAT3 and PLCγ1 plays a critical role in colorectal tumorigenesis. Molecular Cancer Research: MCR ,9 (10), 1418–1428. https://doi.org/10.1158/1541-7786.MCR-11-0147
Zhang, X., Guo, A., Yu, J., Possemato, A., Chen, Y., Zheng, W., … Wang, Z. J. (2007). Identification of STAT3 as a substrate of receptor protein tyrosine phosphatase T. Proceedings of the National Academy of Sciences of the United States of America , 104 (10), 4060–4064. https://doi.org/10.1073/pnas.0611665104
Zhao, S., Sedwick, D., & Wang, Z. (2015). Genetic alterations of protein tyrosine phosphatases in human cancers. Oncogene ,34 (30), 3885–3894. https://doi.org/10.1038/onc.2014.326
Zhao, Y., Scott, A., Zhang, P., Hao, Y., Feng, X., Somasundaram, S., … Wang, Z. (2017). Regulation of paxillin-p130-PI3K-AKT signaling axis by Src and PTPRT impacts colon tumorigenesis. Oncotarget ,8 (30), 48782–48793. https://doi.org/10.18632/oncotarget.10654
Zhao, Y., Zhang, X., Guda, K., Lawrence, E., Sun, Q., Watanabe, T., … Wang, Z. (2010). Identification and functional characterization of paxillin as a target of protein tyrosine phosphatase receptor T.Proceedings of the National Academy of Sciences of the United States of America , 107 (6), 2592–2597. https://doi.org/10.1073/pnas.0914884107